These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24862368)

  • 1. Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice.
    Dong H; Wang S; Zeng Z; Li F; Montalvo-Ortiz J; Tucker C; Akhtar S; Shi J; Meltzer HY; Rice KC; Csernansky JG
    Psychopharmacology (Berl); 2014 Dec; 231(24):4711-22. PubMed ID: 24862368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease.
    Dong H; Murphy KM; Meng L; Montalvo-Ortiz J; Zeng Z; Kolber BJ; Zhang S; Muglia LJ; Csernansky JG
    J Alzheimers Dis; 2012; 28(3):579-92. PubMed ID: 22045495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosterone and related receptor expression are associated with increased beta-amyloid plaques in isolated Tg2576 mice.
    Dong H; Yuede CM; Yoo HS; Martin MV; Deal C; Mace AG; Csernansky JG
    Neuroscience; 2008 Jul; 155(1):154-63. PubMed ID: 18571864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotrophin releasing factor receptor 1 antagonists prevent chronic stress-induced behavioral changes and synapse loss in aged rats.
    Dong H; Keegan JM; Hong E; Gallardo C; Montalvo-Ortiz J; Wang B; Rice KC; Csernansky J
    Psychoneuroendocrinology; 2018 Apr; 90():92-101. PubMed ID: 29477954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of donepezil on amyloid-beta and synapse density in the Tg2576 mouse model of Alzheimer's disease.
    Dong H; Yuede CM; Coughlan CA; Murphy KM; Csernansky JG
    Brain Res; 2009 Dec; 1303():169-78. PubMed ID: 19799879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRF
    Verdouw PM; van Esterik JC; Peeters BW; Millan MJ; Groenink L
    Pharmacol Biochem Behav; 2017 Mar; 154():11-19. PubMed ID: 28089628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent neuroplasticity mechanisms in Alzheimer Tg2576 mice following modulation of brain amyloid-β levels.
    Lilja AM; Röjdner J; Mustafiz T; Thomé CM; Storelli E; Gonzalez D; Unger-Lithner C; Greig NH; Nordberg A; Marutle A
    PLoS One; 2013; 8(3):e58752. PubMed ID: 23554921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat.
    Zorrilla EP; Valdez GR; Nozulak J; Koob GF; Markou A
    Brain Res; 2002 Oct; 952(2):188-99. PubMed ID: 12376179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tonic modulation of anxiety-like behavior by corticotropin-releasing factor (CRF) type 1 receptor (CRF1) within the medial prefrontal cortex (mPFC) in male mice: role of protein kinase A (PKA).
    Miguel TT; Gomes KS; Nunes-de-Souza RL
    Horm Behav; 2014 Jul; 66(2):247-56. PubMed ID: 24848364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease.
    Dong H; Csernansky CA; Martin MV; Bertchume A; Vallera D; Csernansky JG
    Psychopharmacology (Berl); 2005 Aug; 181(1):145-52. PubMed ID: 15778881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alleviation of the effects of endotoxin exposure on behavior and hippocampal IL-1beta by a selective non-peptide antagonist of corticotropin-releasing factor receptors.
    Kohman RA; Tarr AJ; Sparkman NL; Day CE; Paquet A; Akkaraju GR; Boehm GW
    Brain Behav Immun; 2007 Aug; 21(6):824-35. PubMed ID: 17339098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
    Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
    J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
    McCarthy JR; Heinrichs SC; Grigoriadis DE
    Curr Pharm Des; 1999 May; 5(5):289-315. PubMed ID: 10213797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
    Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
    Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.
    Oulès B; Del Prete D; Greco B; Zhang X; Lauritzen I; Sevalle J; Moreno S; Paterlini-Bréchot P; Trebak M; Checler F; Benfenati F; Chami M
    J Neurosci; 2012 Aug; 32(34):11820-34. PubMed ID: 22915123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-Releasing Factor Aggravates Ischemic Stroke Injury by the Inflammatory Activation of Microglia.
    Wu Q; Feng Y; Liu L; Liu Y; Liu X; Zhang L; Li Y; Wang L
    Endocrinology; 2022 Mar; 163(3):. PubMed ID: 35137012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal brain corticotropin releasing factor and somatostatin in a transgenic mouse (TG2576) model of Alzheimer's disease.
    Horgan J; Miguel-Hidalgo JJ; Thrasher M; Bissette G
    J Alzheimers Dis; 2007 Sep; 12(2):115-27. PubMed ID: 17917156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats.
    Marinelli PW; Funk D; Juzytsch W; Harding S; Rice KC; Shaham Y; Lê AD
    Psychopharmacology (Berl); 2007 Dec; 195(3):345-55. PubMed ID: 17705061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Don't stress about CRF: assessing the translational failures of CRF
    Spierling SR; Zorrilla EP
    Psychopharmacology (Berl); 2017 May; 234(9-10):1467-1481. PubMed ID: 28265716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic.
    Sergio Tde O; Spiacci A; Zangrossi H
    Psychoneuroendocrinology; 2014 Nov; 49():321-30. PubMed ID: 25146701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.